fda status bpc-157 tb-500 BPC-157/TB-500 The FDA scheduled a hearing
Description
Research comparing BPC-157 to becaplermin (recombinant human platelet-derived growth factor, a FDA-approved wound healing agent) found that BPC-157 stimulated earlier maturation of granulation tissue and produced more organized collagen in wounds
Heart 91:239240
Therefore, the Centers for Medicare & Medicaid Services (CMS) does not support a programmatic need to recognize the audio-video and audio-only telemedicine E/M codes for payment under Medicare

I think it was just my own Dave Tilley: Googling

Updated July 2026
